Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis.

Garnier S, Vendrell J, Boillot B, Karsenty G, Faure A, Blanc T, Soustelle L, Phe V, Even A, Chartier-Kastler E, Ravasse P, Poinas G, Leizour B, Costa P, Galmiche L, Iborra F, Bouali O, Game X, Solassol J, Kalfa N.

J Urol. 2020 Jan 20:101097JU0000000000000752. doi: 10.1097/JU.0000000000000752. [Epub ahead of print]

PMID:
31957550
2.

PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.

Hamyeh M, Bernex F, Larive RM, Naldi A, Urbach S, Simony-Lafontaine J, Puech C, Bakhache W, Solassol J, Coopman PJ, Hendriks WJAJ, Freiss G.

Theranostics. 2020 Jan 1;10(3):1016-1032. doi: 10.7150/thno.38537. eCollection 2020.

3.

Dzip1 and Fam92 form a ciliary transition zone complex with cell type specific roles in Drosophila.

Lapart JA, Gottardo M, Cortier E, Duteyrat JL, Augière C, Mangé A, Jerber J, Solassol J, Gopalakrishnan J, Thomas J, Durand B.

Elife. 2019 Dec 10;8. pii: e49307. doi: 10.7554/eLife.49307.

4.

The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex.

Kassouf T, Larive RM, Morel A, Urbach S, Bettache N, Marcial Medina MC, Mèrezègue F, Freiss G, Peter M, Boissière-Michot F, Solassol J, Montcourrier P, Coopman P.

Cancers (Basel). 2019 Dec 7;11(12). pii: E1974. doi: 10.3390/cancers11121974.

5.

FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer.

Mangé A, Coyaud E, Desmetz C, Laurent E, Béganton B, Coopman P, Raught B, Solassol J.

Theranostics. 2019 Sep 21;9(23):7003-7015. doi: 10.7150/thno.35561. eCollection 2019.

6.

MIAmS: microsatellite instability detection on NGS amplicons data.

Escudié F, Van Goethem C, Grand D, Vendrell J, Vigier A, Brousset P, Evrard SM, Solassol J, Selves J.

Bioinformatics. 2019 Oct 24. pii: btz797. doi: 10.1093/bioinformatics/btz797. [Epub ahead of print]

PMID:
31647522
7.

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.

Lacombe J, Brengues M, Mangé A, Bourgier C, Gourgou S, Pèlegrin A, Ozsahin M, Solassol J, Azria D.

Radiat Oncol. 2019 Aug 9;14(1):142. doi: 10.1186/s13014-019-1351-8.

8.

Protein interactions study through proximity-labeling.

Béganton B, Solassol I, Mangé A, Solassol J.

Expert Rev Proteomics. 2019 Aug;16(8):717-726. doi: 10.1080/14789450.2019.1638769. Epub 2019 Jul 18.

PMID:
31269821
9.

Challenging BRAF/EGFR co-inhibition in NSCLC using sequential liquid biopsies.

Solassol J, Vendrell JA, Senal R, Audran P, Leenhardt F, Quantin X.

Lung Cancer. 2019 Jul;133:45-47. doi: 10.1016/j.lungcan.2019.05.003. Epub 2019 May 4.

PMID:
31200827
10.

Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.

Alegre N, Perre PV, Bignon YJ, Michel A, Galibert V, Mophawe O, Corsini C, Coupier I, Chiesa J, Robert L, Bernhard L, Picot MC, Bertet H, Macioce V, Bastide N, Solassol J, Rey JM, Thomas F, Carton S, Pujol P.

Psychooncology. 2019 Aug;28(8):1679-1686. doi: 10.1002/pon.5142. Epub 2019 Jun 19.

PMID:
31152683
11.

Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs.

Vendrell JA, Mazieres J, Senal R, Rouquette I, Quantin X, Pujol JL, Roch B, Bouidioua A, Godreuil S, Coyaud E, Brousset P, Solassol J.

Clin Cancer Res. 2019 Jul 15;25(14):4280-4289. doi: 10.1158/1078-0432.CCR-18-2683. Epub 2019 Apr 1.

PMID:
30936123
12.

[New approaches for protein-protein interaction study].

Béganton B, Coyaud E, Mangé A, Solassol J.

Med Sci (Paris). 2019 Mar;35(3):223-231. doi: 10.1051/medsci/2019035. Epub 2019 Apr 1. Review. French.

13.

High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals.

Ouchar Mahamat O, Lounnas M, Hide M, Dumont Y, Tidjani A, Kamougam K, Abderrahmane M, Benavides J, Solassol J, Bañuls AL, Jean-Pierre H, Carrière C, Godreuil S.

BMC Infect Dis. 2019 Feb 28;19(1):205. doi: 10.1186/s12879-019-3838-1.

14.

Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome.

Solassol J, Larrieux M, Leclerc J, Ducros V, Corsini C, Chiésa J, Pujol P, Rey JM.

Hum Mutat. 2019 Jun;40(6):716-720. doi: 10.1002/humu.23725.

PMID:
30815977
15.

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer.

Vendrell JA, Solassol J, Győrffy B, Vilquin P, Jarlier M, Donini CF, Gamba L, Maudelonde T, Rouanet P, Cohen PA.

Front Pharmacol. 2019 Jan 25;9:1581. doi: 10.3389/fphar.2018.01581. eCollection 2018.

16.

High Prevalence of Multidrug-Resistant Escherichia coli in Urine Samples from Inpatients and Outpatients at a Tertiary Care Hospital in Sétif, Algeria.

Nabti LZ, Sahli F, Radji N, Mezaghcha W, Semara L, Aberkane S, Lounnas M, Solassol J, Didelot MN, Jean-Pierre H, Dumont Y, Godreuil S.

Microb Drug Resist. 2019 Apr;25(3):386-393. doi: 10.1089/mdr.2018.0314. Epub 2019 Jan 24.

PMID:
30676258
17.

Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic FGFR3 and FGFR2 mutations.

Bessis D, Petit A, Battistella M, Bourrat E, Girard C, Pallure V, Marque M, Lacour JP, Vitetta A, Bieth É, Selves J, Solassol J, Vendrell J.

Br J Dermatol. 2019 Apr;180(4):955-957. doi: 10.1111/bjd.17581. Epub 2019 Jan 17. No abstract available.

PMID:
30580445
18.

Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.

Vendrell JA, Vilquin P, Larrieux M, Van Goethem C, Solassol J.

J Mol Diagn. 2018 Nov;20(6):754-764. doi: 10.1016/j.jmoldx.2018.06.003. Epub 2018 Jul 25.

19.

Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer.

Solassol J, Quantin X, Larrieux M, Senal R, Audran P, Grand D, Mangé A, Diamandis EP, Vendrell JA.

Clin Chem Lab Med. 2018 Aug 28;56(9):e243-e246. doi: 10.1515/cclm-2017-0967. No abstract available.

PMID:
29626410
20.

Tackling mortality due to childhood tuberculosis.

Godreuil S, Marcy O, Wobudeya E, Bonnet M, Solassol J.

Lancet Public Health. 2018 Apr;3(4):e165. doi: 10.1016/S2468-2667(18)30049-5. Epub 2018 Mar 24. No abstract available.

21.

Extended-spectrum beta-lactamase-producing Escherichia coli in common vampire bats Desmodus rotundus and livestock in Peru.

Benavides JA, Shiva C, Virhuez M, Tello C, Appelgren A, Vendrell J, Solassol J, Godreuil S, Streicker DG.

Zoonoses Public Health. 2018 Jun;65(4):454-458. doi: 10.1111/zph.12456. Epub 2018 Mar 25.

22.

Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.

Vendrell JA, Taviaux S, Béganton B, Godreuil S, Audran P, Grand D, Clermont E, Serre I, Szablewski V, Coopman P, Mazières J, Costes V, Pujol JL, Brousset P, Rouquette I, Solassol J.

Sci Rep. 2017 Oct 2;7(1):12510. doi: 10.1038/s41598-017-12679-8.

23.

Investigation of pre-XDR Beijing Mycobacterium tuberculosis transmission to a healthcare worker in France, 2016.

Appelgren A, Morquin D, Dufour S, Le Moing V, Reynes J, Lotthé A, Parer S, Corbeau C, Aubry A, Sougakoff W, Solassol J, Bonzon L, Dumont Y, Godreuil S.

J Hosp Infect. 2017 Dec;97(4):414-417. doi: 10.1016/j.jhin.2017.06.030. Epub 2017 Jun 30.

PMID:
28669673
24.

Persistence of blaCMY-2-producing Proteus mirabilis in two gull colonies at a 1-year interval in Southern France.

Aberkane S, Compain F, Decré D, Pantel A, Vittecoq M, Solassol J, Bouzinbi N, Jean-Pierre H, Godreuil S.

J Glob Antimicrob Resist. 2017 Jun;9:138-140. doi: 10.1016/j.jgar.2017.05.005. Epub 2017 May 30. No abstract available.

PMID:
28572037
25.

High-throughput detection of clinically targetable alterations using next-generation sequencing.

Vendrell JA, Grand D, Rouquette I, Costes V, Icher S, Selves J, Larrieux M, Barbe A, Brousset P, Solassol J.

Oncotarget. 2017 Jun 20;8(25):40345-40358. doi: 10.18632/oncotarget.15875.

26.

Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.

Naldi A, Larive RM, Czerwinska U, Urbach S, Montcourrier P, Roy C, Solassol J, Freiss G, Coopman PJ, Radulescu O.

PLoS Comput Biol. 2017 Mar 17;13(3):e1005432. doi: 10.1371/journal.pcbi.1005432. eCollection 2017 Mar.

27.

VIM-1 carbapenemase-producing Escherichia coli in gulls from southern France.

Vittecoq M, Laurens C, Brazier L, Durand P, Elguero E, Arnal A, Thomas F, Aberkane S, Renaud N, Prugnolle F, Solassol J, Jean-Pierre H, Godreuil S, Renaud F.

Ecol Evol. 2017 Jan 25;7(4):1224-1232. doi: 10.1002/ece3.2707. eCollection 2017 Feb.

28.

Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.

Vendrell JA, Mau-Them FT, Béganton B, Godreuil S, Coopman P, Solassol J.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E264. doi: 10.3390/ijms18020264. Review.

29.

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.

Solassol J, Vendrell J, Märkl B, Haas C, Bellosillo B, Montagut C, Smith M, O'Sullivan B, D'Haene N, Le Mercier M, Grauslund M, Melchior LC, Burt E, Cotter F, Stieber D, Schmitt FL, Motta V, Lauricella C, Colling R, Soilleux E, Fassan M, Mescoli C, Collin C, Pagès JC, Sillekens P.

PLoS One. 2016 Sep 29;11(9):e0163444. doi: 10.1371/journal.pone.0163444. eCollection 2016.

30.

High Nasal Carriage Rate of Staphylococcus aureus Containing Panton-Valentine leukocidin- and EDIN-Encoding Genes in Community and Hospital Settings in Burkina Faso.

Ouedraogo AS, Dunyach-Remy C, Kissou A, Sanou S, Poda A, Kyelem CG, Solassol J, Bañuls AL, Van De Perre P, Ouédraogo R, Jean-Pierre H, Lavigne JP, Godreuil S.

Front Microbiol. 2016 Sep 13;7:1406. doi: 10.3389/fmicb.2016.01406. eCollection 2016.

31.

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens.

Frouin E, Maudelonde T, Senal R, Larrieux M, Costes V, Godreuil S, Vendrell JA, Solassol J.

PLoS One. 2016 Jul 28;11(7):e0158698. doi: 10.1371/journal.pone.0158698. eCollection 2016.

32.

An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.

Mangé A, Dimitrakopoulos L, Soosaipillai A, Coopman P, Diamandis EP, Solassol J.

J Proteomics. 2016 Jun 16;142:114-21. doi: 10.1016/j.jprot.2016.04.050. Epub 2016 May 7.

PMID:
27168011
33.

Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.

Chazel M, Marchandin H, Keck N, Terru D, Carrière C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Bañuls AL, Choisy M, Solassol J, Aubry A, Godreuil S.

Ann Clin Microbiol Antimicrob. 2016 May 6;15:30. doi: 10.1186/s12941-016-0145-1.

34.

First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso.

Ouédraogo AS, Compain F, Sanou M, Aberkane S, Bouzinbi N, Hide M, Sangaré L, Ouédraogo-Traoré R, Jean-Pierre H, Vendrell J, Solassol J, Decré D, Godreuil S.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3240-2. doi: 10.1128/AAC.00147-16. Print 2016 May. No abstract available.

35.

Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.

Shi L, Gehin T, Chevolot Y, Souteyrand E, Mangé A, Solassol J, Laurenceau E.

Anal Bioanal Chem. 2016 Feb;408(5):1497-506. doi: 10.1007/s00216-015-9257-2. Epub 2015 Dec 29.

PMID:
26715250
36.

High Prevalence of SXT/R391-Related Integrative and Conjugative Elements Carrying blaCMY-2 in Proteus mirabilis Isolates from Gulls in the South of France.

Aberkane S, Compain F, Decré D, Dupont C, Laurens C, Vittecoq M, Pantel A, Solassol J, Carrière C, Renaud F, Brieu N, Lavigne JP, Bouzinbi N, Ouédraogo AS, Jean-Pierre H, Godreuil S.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1148-52. doi: 10.1128/AAC.01654-15. Print 2016 Feb.

37.

Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting.

Mourah S, Denis MG, Narducci FE, Solassol J, Merlin JL, Sabourin JC, Scoazec JY, Ouafik L, Emile JF, Heller R, Souvignet C, Bergougnoux L, Merlio JP.

PLoS One. 2015 Mar 19;10(3):e0120232. doi: 10.1371/journal.pone.0120232. eCollection 2015.

38.

Establishment and characterization of a cell line from human circulating colon cancer cells.

Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabières C.

Cancer Res. 2015 Mar 1;75(5):892-901. doi: 10.1158/0008-5472.CAN-14-2613. Epub 2015 Jan 15.

39.

Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.

Bourgier C, Lacombe J, Solassol J, Mange A, Pèlegrin A, Ozsahin M, Azria D.

Crit Rev Oncol Hematol. 2015 Mar;93(3):312-9. doi: 10.1016/j.critrevonc.2014.11.004. Epub 2014 Nov 22. Review.

PMID:
25497158
40.

Cutaneous epithelial tumors induced by vemurafenib involve the MAPK and Pi3KCA pathways but not HPV nor HPyV viral infection.

Frouin E, Guillot B, Larrieux M, Tempier A, Boulle N, Foulongne V, Girard C, Costes V, Solassol J.

PLoS One. 2014 Oct 31;9(10):e110478. doi: 10.1371/journal.pone.0110478. eCollection 2014.

41.

Use of autoantibodies to detect the onset of breast cancer.

Lacombe J, Mangé A, Solassol J.

J Immunol Res. 2014;2014:574981. doi: 10.1155/2014/574981. Epub 2014 Jul 21. Review.

42.

Comparative evaluation of the new FDA approved THxID™-BRAF test with High Resolution Melting and Sanger sequencing.

Marchant J, Mange A, Larrieux M, Costes V, Solassol J.

BMC Cancer. 2014 Jul 19;14:519. doi: 10.1186/1471-2407-14-519.

43.

A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.

Lacombe J, Mangé A, Bougnoux AC, Prassas I, Solassol J.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1834-42. doi: 10.1158/1055-9965.EPI-14-0267. Epub 2014 Jun 23.

44.

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J.

Ann Oncol. 2014 Jan;25(1):126-31. doi: 10.1093/annonc/mdt418. Epub 2013 Nov 26.

45.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

46.

Elevated concentrations of milk β2-microglobulin are associated with increased risk of breastfeeding transmission of HIV-1 (Vertical Transmission Study).

Mangé A, Tuaillon E, Viljoen J, Nagot N, Bendriss S, Bland RM, Newell ML, Van de Perre P, Solassol J.

J Proteome Res. 2013 Dec 6;12(12):5616-25. doi: 10.1021/pr400578h. Epub 2013 Nov 5.

PMID:
24144106
47.

[Intrinsic radiosensitivity: predictive assays that will change daily practice].

Lacombe J, Riou O, Solassol J, Mangé A, Bourgier C, Fenoglietto P, Pèlegrin A, Ozsahin M, Azria D.

Cancer Radiother. 2013 Oct;17(5-6):337-43. doi: 10.1016/j.canrad.2013.07.137. Epub 2013 Aug 30. Review. French.

PMID:
23999252
48.

Morphological and molecular analysis of lung cancer biopsies fixed in RCL2.

Khellaf L, Larrieux M, Serre I, Costes V, Solassol J.

Histopathology. 2013 Jul;63(1):137-9. doi: 10.1111/his.12120. Epub 2013 Apr 24. No abstract available.

PMID:
23614466
49.

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma.

Szablewski V, Solassol J, Poizat F, Larrieux M, Crampette L, Mange A, Bascoul-Mollevi C, Costes V.

Int J Mol Sci. 2013 Mar 4;14(3):5170-81. doi: 10.3390/ijms14035170.

50.

Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.

Lacombe J, Azria D, Mange A, Solassol J.

Expert Rev Proteomics. 2013 Feb;10(1):33-42. doi: 10.1586/epr.12.68. Review.

PMID:
23414358

Supplemental Content

Loading ...
Support Center